A low level of IRF8 expression in tumors is associated with poor prognosis in human hepatocellular carcinoma (HCC), and gene set enrichment analysis identified the IFNγ and PD-1 signaling signatures as the top suppressed pathways in patients with IRF8-low HCC [52]. This evidence concerns the gene IRF8 and hepatocellular carcinoma.